The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Bhagwagar, Z.
* Articles by Harmer, C. J.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Bhagwagar, Z.
* Articles by Harmer, C. J.
Related Collections
* Depression
* Antidepressants
Am J Psychiatry 161:166-168, January 2004
© 2004 American Psychiatric Association


Brief Report

Normalization of Enhanced Fear Recognition by Acute SSRI Treatment in Subjects With a Previous History of Depression

Zubin Bhagwagar, M.D., M.R.C.Psych., Philip J. Cowen, M.D., F.R.C.Psych., Guy M. Goodwin, D.Phil., F.R.C.Psych., and Catherine J. Harmer, D.Phil.

OBJECTIVE: The present study aimed to 1) assess facial expression recognition in subjects with a previous history of major depressive disorder relative to subjects with no history of depression and 2) characterize the effects of acute citalopram infusion on recognition performance for both groups. METHOD: Unmedicated euthymic women with a history of major depression and matched comparison subjects with no history of depression were given a facial expression recognition task following intravenous infusion of saline or citalopram (10 mg) in a double-blind, between-group design. RESULTS: Following saline infusion, subjects with a previous history of depression showed a selectively greater recognition of fear relative to the subjects with no history of depression. The abnormal fear processing observed in the subjects with a previous history of depression was normalized following citalopram infusion, an effect that was opposite to that seen with the subjects with no history of depression. CONCLUSIONS: These results suggest that increased recognition of fear is a trait vulnerability marker for depression and that this is normalized following a single dose of citalopram.




This article has been cited by other articles:


Home page
Br. J. PsychiatryHome page
S. E. Murphy, R. Norbury, U. O'Sullivan, P. J. Cowen, and C. J. Harmer
Effect of a single dose of citalopram on amygdala response to emotional faces
The British Journal of Psychiatry, June 1, 2009; 194(6): 535 - 540.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
W. Merens, L. Booij, P. J. Haffmans, and A. van der Does
The effects of experimentally lowered serotonin function on emotional information processing and memory in remitted depressed patients
J Psychopharmacol, August 1, 2008; 22(6): 653 - 662.
[Abstract] [PDF]


Home page
Br. J. PsychiatryHome page
S. HAFIZI, P. CHANDRA, and J. COWEN
Neurokinin-1 receptor antagonists as novel antidepressants: trials and tribulations
The British Journal of Psychiatry, October 1, 2007; 191(4): 282 - 284.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
M. J. Taylor, N. Freemantle, J. R. Geddes, and Z. Bhagwagar
Early Onset of Selective Serotonin Reuptake Inhibitor Antidepressant Action: Systematic Review and Meta-analysis.
Arch Gen Psychiatry, November 1, 2006; 63(11): 1217 - 1223.
[Abstract] [Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2004 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org